REFERENCES
1. Saletta F, Dalla Pozza L, Byrne JA. Genetic causes of cancer predisposition in children and adolescents. Transl Pediatr . 2015;4(2):67-75. doi:10.3978/j.issn.2224-4336.2015.04.08
2. Zhang J, Walsh MF, Wu G, et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med . 2015;373(24):2336-2346. doi:10.1056/NEJMoa1508054
3. Grobner SN, Worst BC, Weischenfeldt J, et al. The landscape of genomic alterations across childhood cancers. Nature . 2018;555(7696):321-327. doi:10.1038/nature25480
4. Ma X, Liu Y, Liu Y, et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.Nature . 2018. doi:10.1038/nature25795
5. Sweet-Cordero EA, Biegel JA. The genomic landscape of pediatric cancers: Implications for diagnosis and treatment. Science . 2019;363(6432):1170-1175. doi:10.1126/science.aaw3535
6. Agha MM, Williams JI, Marrett L, To T, Zipursky A, Dodds L. Congenital abnormalities and childhood cancer: A cohort record-linkage study. Cancer . 2005. doi:10.1002/cncr.20985
7. Merks JHM, Caron HN, Hennekam RCM. High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet A . 2005;134A(2):132-143. doi:10.1002/ajmg.a.30603
8. Scollon S, Anglin AK, Thomas M, Turner JT, Wolfe Schneider K. A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes. J Genet Couns . 2017;26(3):387-434. doi:10.1007/s10897-017-0077-8
9. Heck JE, Meyers TJ, Lombardi C, et al. Case-control study of birth characteristics and the risk of hepatoblastoma. Cancer Epidemiol . 2013. doi:10.1016/j.canep.2013.03.004
10. Stiller CA, Pritchard J, Steliarova-Foucher E. Liver cancer in European children: incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer . 2006;42(13):2115-2123. doi:10.1016/j.ejca.2006.05.011
11. Czauderna P, Garnier H. Hepatoblastoma: current understanding, recent advances, and controversies. F1000Research . 2018;7:53. doi:10.12688/f1000research.12239.1
12. de Camargo B, de Oliveira Ferreira JM, de Souza Reis R, Ferman S, de Oliveira Santos M, Pombo-de-Oliveira MS. Socioeconomic status and the incidence of non-central nervous system childhood embryonic tumours in Brazil. BMC Cancer . 2011. doi:10.1186/1471-2407-11-160
13. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA).Incidência, Mortalidade e Morbidade Hospitalar Por Câncer Em Crianças, Adolescentes e Adultos Jovens No Brasil: Informações Dos Registros de Câncer e Do Sistema de Mortalidade . (Coordenação de Prevenção e Vigilância, ed.). Rio de Janeiro: INCA; 2016.
14. Aguiar TFM, Rivas MP, Costa S, et al. Insights Into the Somatic Mutation Burden of Hepatoblastomas From Brazilian Patients. Front Oncol . 2020;10:556. doi:10.3389/fonc.2020.00556
15. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr . 1998;132(3 Pt 1):398-400.
16. Kim SY, Jung S-H, Kim MS, et al. Genomic profiles of a hepatoblastoma from a patient with Beckwith-Wiedemann syndrome with uniparental disomy on chromosome 11p15 and germline mutation of APC and PALB2. Oncotarget . 2017. doi:10.18632/oncotarget.20515
17. Hirschman BA, Pollock BH, Tomlinson GE. The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J Pediatr . 2005. doi:10.1016/j.jpeds.2005.04.019
18. Pereira EM, Marion R, Ramesh KH, Kim JS, Ewart M, Ricafort R. Hepatoblastoma in a mosaic trisomy 18 patient. J Pediatr Hematol Oncol . 2012;34(4):e145-8. doi:10.1097/MPH.0b013e3182459ee8
19. Turcotte LM, Georgieff MK, Ross JA, et al. Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children’s Oncology Group. Pediatr Blood Cancer . 2014;61(11):2018-2023. doi:10.1002/pbc.25128
20. Pinto RB, Ramos ARL, Backes AN, et al. Hirschsprung disease and hepatoblastoma: case report of a rare association. Sao Paulo Med J . 2016;134(2):171-175. doi:10.1590/1516-3180.2014.9200311
21. Best KE, Addor M-C, Arriola L, et al. Hirschsprung’s disease prevalence in Europe: a register based study. Birth Defects Res A Clin Mol Teratol . 2014;100(9):695-702. doi:10.1002/bdra.23269
22. Heuckeroth RO. Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes. Nat Rev Gastroenterol Hepatol . 2018;15(3):152-167. doi:10.1038/nrgastro.2017.149
23. Haricharan RN, Georgeson KE. Hirschsprung disease. Semin Pediatr Surg . 2008;17(4):266-275. doi:10.1053/j.sempedsurg.2008.07.005
24. Salehpour S, Hashemi-Gorji F, Soltani Z, Ghafouri-Fard S, Miryounesi M. Association of a Novel Nonsense Mutation in KIAA1279 with Goldberg-Shprintzen Syndrome. Iran J child Neurol . 2017;11(1):70-74. http://www.ncbi.nlm.nih.gov/pubmed/28277559. Accessed August 26, 2019.
25. Badner JA, Sieber WK, Garver KL, Chakravarti A. A genetic study of Hirschsprung disease. Am J Hum Genet . 1990;46(3):568-580.
26. Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet . 2008;45(1):1-14. doi:10.1136/jmg.2007.053959
27. Camilleri M, Wieben E, Eckert D, et al. Familial chronic megacolon presenting in childhood or adulthood: Seeking the presumed gene association. Neurogastroenterol Motil . 2019;31(4):e13550. doi:10.1111/nmo.13550
28. Sambrook J, Russell DW. Purification of nucleic acids by extraction with phenol:chloroform. CSH Protoc . 2006;2006(1). doi:10.1101/pdb.prot4455
29. Campos AHJFM, Silva AA, Mota LDDC, et al. The value of a tumor bank in the development of cancer research in Brazil: 13 years of experience at the a C camargo hospital. Biopreserv Biobank . 2012;10(2):168-173. doi:10.1089/bio.2011.0032
30. Li H. Aligning Sequence Reads, Clone Sequences and Assembly Contigs with BWA-MEM .; 2013. http://github.com/lh3/bwa. Accessed May 18, 2020.
31. McKenna A, Hanna M, Banks E, et al. The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data.Genome Res . 2010;20(9):1297-1303. doi:10.1101/gr.107524.110
32. Challis D, Yu J, Evani US, et al. An integrative variant analysis suite for whole exome next-generation sequencing data. BMC Bioinformatics . 2012;13(1). doi:10.1186/1471-2105-13-8
33. Stelzer G, Plaschkes I, Oz-Levi D, et al. VarElect: The phenotype-based variation prioritizer of the GeneCards Suite. BMC Genomics . 2016. doi:10.1186/s12864-016-2722-2
34. Köhler S, Carmody L, Vasilevsky N, et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Res . 2019. doi:10.1093/nar/gky1105
35. Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL, Guideline Development Group, American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and National Society of Genetic Counselors Practice Guidelines Committee. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med . 2015;17(1):70-87. doi:10.1038/gim.2014.147
36. LSue Richards, PhD1 , Nazneen Aziz, PhD2, 16 , Sherri Bale, PhD3 , David Bick M, , Soma Das P, Julie Gastier-Foster, PhD6, 7, 8, Wayne W. Grody, MD, PhD9, 10, 11, Madhuri Hegde P, et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Sue. Genet Med . 2015. doi:10.1038/gim.2015.30.Standards
37. Kopanos C, Tsiolkas V, Kouris A, et al. VarSome: the human genomic variant search engine. Bioinformatics . 2019. doi:10.1093/bioinformatics/bty897
38. Oliveira D, Leal GF, Sertie AL, et al. 10q23.31 microduplication encompassing PTEN decreases mTOR signalling activity and is associated with autosomal dominant primary microcephaly. J Med Genet . October 2018. doi:10.1136/jmedgenet-2018-105471
39. Agha MM, Williams JI, Marrett L, To T, Zipursky A, Dodds L. Congenital abnormalities and childhood cancer. Cancer . 2005;103(9):1939-1948. doi:10.1002/cncr.20985
40. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin . 2017;67(1):7-30. doi:10.3322/caac.21387
41. Norwood MS, Lupo PJ, Chow EJ, et al. Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013. PLoS One . 2017;12(6):e0179006. doi:10.1371/journal.pone.0179006
42. Ansell P, Mitchell CD, Roman E, Simpson J, Birch JM, Eden TOB. Relationships between perinatal and maternal characteristics and hepatoblastoma: a report from the UKCCS. Eur J Cancer . 2005;41(5):741-748. doi:10.1016/j.ejca.2004.10.024
43. Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet . 1997;60(3):474-485.
44. Butler Tjaden NE, Trainor PA. The developmental etiology and pathogenesis of Hirschsprung disease. Transl Res . 2013;162(1):1-15. doi:10.1016/j.trsl.2013.03.001
45. Maddox DM, Collin GB, Ikeda A, et al. A Mutation in Syne2 Causes Early Retinal Defects in Photoreceptors, Secondary Neurons, and Muller Glia. Invest Ophthalmol Vis Sci . 2015;56(6):3776-3787. doi:10.1167/iovs.14-16047
46. Falk N, Kessler K, Schramm S-F, et al. Functional analyses of Pericentrin and Syne-2 interaction in ciliogenesis. J Cell Sci . 2018;131(16). doi:10.1242/jcs.218487
47. Takayama K, Salazar EP, Lehmann A, Stefanini M, Thompson LH, Weber CA. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D. Cancer Res . 1995;55(23):5656-5663. http://www.ncbi.nlm.nih.gov/pubmed/7585650. Accessed August 6, 2019.
48. Liu H, Rudolf J, Johnson KA, et al. Structure of the DNA repair helicase XPD. Cell . 2008;133(5):801-812. doi:10.1016/j.cell.2008.04.029
49. Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum.Orphanet J Rare Dis . 2011. doi:10.1186/1750-1172-6-70
50. Aoki Y, Niihori T, Kawame H, et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet . 2005;37(10):1038-1040. doi:10.1038/ng1641
51. Aoki Y, Matsubara Y. Ras/MAPK syndromes and childhood hemato-oncological diseases. Int J Hematol . 2013;97(1):30-36. doi:10.1007/s12185-012-1239-y
52. Gripp KW, Innes AM, Axelrad ME, et al. Costello syndrome associated with novel germline HRAS mutations: An attenuated phenotype? Am J Med Genet Part A . 2008. doi:10.1002/ajmg.a.32227
53. Chiu ATG, Leung GKC, Chu YWY, Gripp KW, Chung BHY. A novel patient with an attenuated Costello syndrome phenotype due to an HRAS mutation affecting codon 146—Literature review and update. Am J Med Genet Part A . 2017. doi:10.1002/ajmg.a.38118
54. Hughes LJ, Michels V V. Risk of hepatoblastoma in familial adenomatous polyposis. Am J Med Genet . 1992;43(6):1023-1025. doi:10.1002/ajmg.1320430621
55. Hirschman BA, Pollock BH, Tomlinson GE. The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J Pediatr . 2005;147(2):263-266. doi:10.1016/j.jpeds.2005.04.019
56. Pangon L, Mladenova D, Watkins L, et al. MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.Int J Cancer . 2015;136(1):55-64. doi:10.1002/ijc.28967
57. Fukuyama R, Niculaita R, Ng KP, et al. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses β-catenin-dependent transcription. Oncogene . 2008;27(46):6044-6055. doi:10.1038/onc.2008.204
58. Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature . 1997;386(6627):761,763. doi:10.1038/386761a0
59. Currey N, Jahan Z, Caldon CE, et al. Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer. CMGH . 2019;7(4):819-839. doi:10.1016/j.jcmgh.2019.01.009
60. Erwin CR, Warner BW. Hirschsprung lost his nerve.Gastroenterology . 2003;125(6):1900-1902. doi:10.1053/j.gastro.2003.07.019
61. Pectasides E, Bass AJ. ERBB2 emerges as a new target for colorectal cancer. Cancer Discov . 2015;5(8):799-801. doi:10.1158/2159-8290.CD-15-0730
62. Shiels A, Hejtmancik JF. Genetics of human cataract. Clin Genet . 2013;84(2):120-127. doi:10.1111/cge.12182
63. Zhai Y, Li J, Yu W, et al. Targeted Exome Sequencing of Congenital Cataracts Related Genes: Broadening the Mutation Spectrum and Genotype-Phenotype Correlations in 27 Chinese Han Families. Sci Rep . 2017;7(1):1-9. doi:10.1038/s41598-017-01182-9
64. Francis PJ, Berry V, Bhattacharya SS, Moore AT. The genetics of childhood cataract. J Med Genet . 2000;37(7):481-488. doi:10.1136/jmg.37.7.481
65. Sivasubramaniam S, Sun X, Pan Y-R, Wang S, Lee EY-HP. Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1. Genes Dev . 2008;22(5):587-600. doi:10.1101/gad.1627708
66. Stejskalova L, Pavek P. The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta. Curr Pharm Biotechnol . 2011;12(5):715-730.
67. Delescluse C, Lemaire G, de Sousa G, Rahmani R. Is CYP1A1 induction always related to AHR signaling pathway? Toxicology . 2000;153(1-3):73-82. doi:10.1016/s0300-483x(00)00305-x
68. Manolescu DC, El-Kares R, Lakhal-Chaieb L, Montpetit A, Bhat P V, Goodyer P. Newborn serum retinoic acid level is associated with variants of genes in the retinol metabolism pathway. Pediatr Res . 2010;67(6):598-602. doi:10.1203/PDR.0b013e3181dcf18a
69. Ricard MJ, Gudas LJ. Cytochrome P450 Cyp26a1 alters spinal motor neuron subtype identity in differentiating embryonic stem cells. J Biol Chem . 2013;288(40):28801-28813. doi:10.1074/jbc.M113.474254
70. Martucciello G. Hirschsprung’s disease, one of the most difficult diagnoses in pediatric surgery: A review of the problems from clinical practice to the bench. Eur J Pediatr Surg . 2008;18(3):140-149. doi:10.1055/s-2008-1038625